Identified two types of copy number aberrations in high-risk Neuroblastoma that are associated with extremely poor outcome.
We describe the early and late effects of ALK inhibitor TAE684 treatment on the neuroblastoma transcriptome.
We highlight several practical advantages and disadvantages of the different trajectory inference methods.
A customized platform for high-resolution copy number analysis of known and candidate retinal dystrophy genes and retinal noncoding RNAs.
Development of novel biomarkers for assessing the outcome of neuroblastoma patients.